Search Results 761-770 of 17106 for postaglandin

1. Breast cancer - Doctors and departments - Mayo Clinic

   Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

2. Prostate cancer - Doctors and departments - Mayo Clinic

   Learn about detection, diagnostic approaches, treatment options and advances for prostate cancer, including robotic prostatectomy and current research.

3. Breast cancer - Doctors and departments - Mayo Clinic

   Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

4. A Study Comparing Either Cervical Spine, Head, Temporal Bone or Vasculature Treated with Metallic Implants Imaged with CT or MRI or Cerebral Angiogram to a MRI Zero Echo Time (ZTE) MRI Sequence - Mayo Clinic

   A Study Comparing Either Cervical Spine, Head, Temporal Bone or Vasculature Treated with Metallic Implants Imaged with CT or MRI or Cerebral Angiogram to a MRI ...

5. Breast cancer - Doctors and departments - Mayo Clinic

   Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

6. A Study to Evaluate the Effectiveness of Using the Heated Eye Pad and Scorpion-1 Touch on Meibomian Gland Dysfunction - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

7. Ipilimumab With or Without Talimogene Laherparepvec in Unresected Melanoma - Mayo Clinic

   About this study. Phase 1b of the study will evaluate the safety of talimogene laherparepvec in combination with ipilimumab. Phase 2 is a randomized study ...

8. Use of Tolvaptan to Reduce Urinary Supersaturation: a Pilot Proof of Principle Study - Mayo Clinic

   In this study the investigators propose to use a daily dose of 45 mg (30 mg at 8 AM and 15 mg at 4 PM). This relatively small well-tolerated dose is likely to ...

9. A Study of the Natural History of Monoclonal Gammopathy of Undetermined Significance (MGUS) Over Time - Mayo Clinic

   About this study. The primary purpose of this study is to evaluate the risk of progression from Monoclonal Gammopathy of Undetermined Significance (MGUS) to ...

10. A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null Tumors - Mayo Clinic

    Phase 2 only: To assess preliminary antitumor activity by overall response rate (ORR) as measured by Response Evaluation Criteria in Solid Tumors (RECIST) v1.1 ...